Product Pipeline

Pipeline Overview

Sagene is currently targeting erectile dysfunction (ED), pulmonary arterial hypertension (PAH), pain/inflammation and cardiovascular diseases through proprietary drug combinations. These indications represent large markets for which current treatments have serious side effects or limitations.